A large language model demonstrated proficiency in ophthalmology, matching or outperforming specialists in the management of glaucoma and retina cases. Medscape Medical News
Tag: Ophthalmology
Will 2024 Be Easier on the Eyes?
Longer-acting drugs, novel implants, and oral and topical agents that aim to solve the burden of frequent injections and office visits for retinal disease are on the horizon. Medscape Medical News
For Retina Specialists, 2024 Is a Time to Try New Tools
This is a year for ophthalmologists to get acclimated with three blockbuster retina drugs approved in 2023, get reacclimated with a returning implant, and to brace for 2025 and beyond. Medscape Medical News
2024 Will See Major Advances in Glaucoma Care
Three new treatments for dry eye disease and a new procedure and remote monitoring platform for glaucoma are due to debut in 2024, with more in the pipeline. Medscape Medical News
Metformin Shows Potential to Prevent Neovascular AMD
A case-control study of 174,000 individuals found that use of metformin was associated with a reduced odds of developing wet, age-related macular degeneration. Medscape Medical News
FDA Approves Implant for Glaucoma
An intracameral implant that releases travoprost into the eye over an extended period to lower intraocular pressure in glaucoma and ocular hypertension will be available commercially in early 2024. Medscape Medical News
Report: Kidney Disease Evident in These Eye Issues
An analysis of four new studies found that retinal and choroidal thickness in the back of the eye correlates with kidney function in patients with chronic kidney disease. Medscape Medical News
Phone Attachment for Pupil Measurements with Any Skin Tone
A research team at the University of California San Diego have developed a smartphone attachment that can provide information on changes in pupil size, which can be used to assess neurological phenomena, such as traumatic brain injury and Alzheimer’s disease. Such changes in pupil size have been difficult to characterize in the past in those […]
AAO 2023: Improving Patients’ QOL in Diabetic Macular Edema
Dr Sunir Garg reflects on how highlights from AAO 2023 will affect his patients with diabetic macular edema. Medscape
Oral Therapy Shown to Preserve Retina in Stargardt Disease
A once-daily pill of modified vitamin A slowed the rate of retinal degeneration in patients with Stargardt disease, a rare genetic eye disease that can cause vision loss. Medscape Medical News
Pediatric PKP Graft Failure More Likely at Younger Ages
Performing other eye procedures during corneal transplantation in children may increase the odds of a poor outcome, according to research presented at the American Academy of Ophthalmology 2023 annual meeting. Medscape Medical News
At 2 Years, Anti-VEGF Treatment, Laser Equal for ROP: Study
For treatment of retinopathy of prematurity, intravitreal aflibercept (Eylea) and laser photocoagulation showed equivocal results at age 2 years, a European-based clinical trial found. Medscape Medical News
GLP-1s Don’t Appear to Worsen Diabetic Retinopathy
Most patients with diabetic retinopathy who take the GLP-1 agonist semaglutide don’t experience a worsening of the condition, a new study found, but they still require screening and follow-up. Medscape Medical News
Novel Approach to Dry Eye Shows Promise
The experimental drug tavilermide appeared to be effective in patients with the worst symptoms of the condition, a new study finds. Medscape Medical News
Study Shows Tarcocimab May Improve Diabetic Retinopathy
A phase 3 trial showed that tarcocimab, a biopolymer with a vascular growth factor antibody, improved vision and anatomical markers in patients with early stage diabetic retinopathy. Medscape Medical News
Children With Sickle Cell Disease at Risk for Vision Loss
Previously thought to be age-dependent, retinopathy affects a full third of children with sickle cell disease, a new study found. Medscape Medical News
FDA Recalls Dozens More Eye Drop Products
More than 2 dozen products could cause eye infections or blindness, after bacterial contamination and unsanitary conditions were found at a manufacturing facility, the agency said. WebMD Health News
Faricimab Efficacy, Safety Hold Up in Real-World Study
A real-world study of faricimab in neovascular age-related macular degeneration showed visual and anatomical improvement in line with phase 3 trials in treatment-naive and previously treated eyes. Medscape Medical News
High-Dose Aflibercept Sustains Outcomes Over 96 Weeks
The recently approved 8-mg dose of aflibercept has shown sustained improvement in vision and anatomical markers out to 96 weeks, according to updated clinical trial results. Medscape Medical News
Eye Specialists Miss Mental Health Issues Linked to AMD
Patients with age-related macular degeneration are known to experience high rates of depression and anxiety, but clinicians often miss the problems, prompting a call for a consensus statement. Medscape Medical News